Zimmer Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Zimmer Partners’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-383,100	Closed	-$5.89M	–	163
2025 Q3	$5.89M	Sell	383,100 -222,700	-37%	-$2.91M	0.13%	96
2025 Q2	$5.67M	Buy	605,800 +392,641	+184%	+$4.32M	0.12%	108
2025 Q1	$2.62M	Buy	+213,159	New	+$3.01M	0.05%	142
2024 Q3	–	Sell	-155,000	Closed	-$3.18M	–	179
2024 Q2	$3.18M	Hold	155,000	–	–	0.06%	119
2024 Q1	$3.69M	Sell	155,000 -120,100	-44%	-$2.68M	0.08%	102
2023 Q4	$5.94M	Buy	+275,100	New	+$4.23M	0.22%	63

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Zimmer Partners's SNDX Position: Q4 2025 in Review

Zimmer Partners sold out of Syndax Pharmaceuticals (SNDX) in Q4 2025, closing a stake of 383,100 shares — an estimated $5.89M sold.

Zimmer Partners first reported a position in SNDX in Q4 2023 and held it in 6 quarters. The position peaked at $5.94M in Q4 2023. 229 funds tracked by Wall St. Rank hold SNDX as of Q4 2025.

Zimmer Partners reported no remaining Syndax Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Zimmer Partners sold 383,100 Syndax Pharmaceuticals shares in Q4 2025, an estimated $5.89M.
Zimmer Partners first reported a position in Syndax Pharmaceuticals in Q4 2023 and held it in 6 quarters.
Zimmer Partners's Syndax Pharmaceuticals position peaked at $5.94M in Q4 2023.
229 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2025.

Based on Zimmer Partners's 13F filing for Q4 2025, filed 17 Feb 2026.